Recent Trends and Outcome of Mitral Valve Surgery.
10.4070/kcj.1998.28.7.1059
- Author:
Jae Hwan LEE
;
Jae Kwan SONG
;
Hyun Sook KIM
;
Young Hak KIM
;
Min Kyu KIM
;
Hee Young LIM
;
Duk Hyun KANG
;
Jae Joong KIM
;
Seong Wook PARK
;
Seung Jung PARK
;
Hyun SONG
;
Jay Won LEE
;
Dong Man SEO
;
Meong Gun SONG
- Publication Type:Original Article
- Keywords:
Mitral valve surgery;
Mortality;
Survival
- MeSH:
Cardiopulmonary Bypass;
Death;
Disease-Free Survival;
Endocarditis;
Follow-Up Studies;
Heart;
Hemorrhage;
Humans;
Korea;
Male;
Mitral Valve Insufficiency;
Mitral Valve Stenosis;
Mitral Valve*;
Mortality;
Pathology;
Reoperation;
Survivors;
Thromboembolism;
Ventricular Function, Left
- From:Korean Circulation Journal
1998;28(7):1059-1068
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND AND OBJECTIVES: Recently, in mitral valve surgery, valvuloplasty or valve repair was successfully introduced to improve postoperative left ventricular function and to decrease operative mortality. However, the real impact of this technique on daily practice in Korea was not systematically assessed. MATERIALS AND METHOD: The operative methods, postoperative death, follow-up results and their contributing factors were analysed among patients who underwent mitral valve surgery at our institution. RESULTS: 1) From June 1989 to December 1996, 416 patients (186 males, mean age 48+/-13 years) underwent mitral valve surgery. Dominant mitral stenosis (MS) was the main pathology in 167 patients; dominant mitral regurgitation (MR) and balanced mitral stenoinsufficiency (MSR) in 197 and 52 respectively. 2) In MS, valve replacement was performed in 91% whereas commissurotomy in 9%. However, in MR, the rates of valve repair surgery has increased up to 60% of the total surgical procedures for the past three years. 3) The overall operative mortality was 4% (18/416). It was significantly lower in valve repair compaired with valve replacement (0% vs. 6%; p=0.003). In MS, factors associated with high mortality were longer cardiopulmonary bypass and aortic cross clamp time. In MR, high mortality was associated with diabetes, endocarditis, valve replacement and longer cardiopulmonary bypass time. 4) The 7-year late survival among operative survivors was 95+/-2% in MS, which was singnificantly higher than that in MR (80+/-6%, p=0.04). 5) In MR, the 4-year cardiac event-free survival among operative survivors (absence of cardiac death, reoperation, bleeding, endocarditis, thromboembolism, or development of heart failure) was significantly higher in valve repair group than in valve replacement (84+/-7 vs. 76+/-5%; p=0.03). CONCLUSION: The overall outcomes of recent mitral valve surgery were satisfactory. In MR, valve repair surgery seemed to be an established method to decrease operative mortality and long-term complications.
